127 related articles for article (PubMed ID: 37344195)
1. Retroperitoneal tumour resection in fifteen consecutive cases: Single centre experience.
Novotný R; Donátová Z; Büchler T; Kristek J; Froněk J; Janousek L
Rozhl Chir; 2023; 102(4):154-158. PubMed ID: 37344195
[TBL] [Abstract][Full Text] [Related]
2. [Postchemotherapy residual tumour resection in complex metastatic sites of advanced testicular germ cell tumours].
Paffenholz P; Pfister D; Heidenreich A
Urologe A; 2016 May; 55(5):632-40. PubMed ID: 26820659
[TBL] [Abstract][Full Text] [Related]
3. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP
BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110
[TBL] [Abstract][Full Text] [Related]
4. Post-chemotherapy retroperitoneal lymph node dissection in the management of metastatic testis cancer: the 16-year experience in an Irish setting.
Considine S; Heaney R; Conroy R; Thornhill JA
Ir J Med Sci; 2016 Nov; 185(4):901-907. PubMed ID: 26692387
[TBL] [Abstract][Full Text] [Related]
5. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
[No Abstract] [Full Text] [Related]
6. Excision of Postchemotherapy Residual Retroperitoneal Mass in Testicular Cancer.
Nauman M; Hussain M; Kumar P; Mohsin R; Sultan G; Hashmi A
J Coll Physicians Surg Pak; 2022 Aug; 32(8):1089-1091. PubMed ID: 35932143
[TBL] [Abstract][Full Text] [Related]
7. Retroperitoneal teratoma with somatic malignant transformation: a papillary renal cell carcinoma in a testicular germ cell tumour metastasis following platinum-based chemotherapy.
Zeh N; Wild PJ; Bode PK; Kristiansen G; Moch H; Sulser T; Hermanns T
BMC Urol; 2013 Feb; 13():9. PubMed ID: 23402579
[TBL] [Abstract][Full Text] [Related]
8. Clinical Management and Outcome in Extreme Retroperitoneal Growing Teratoma Syndrome of Testicular Origin - Clinical Management and Effect of the Treatment.
Huľová S; Aziri R; Chovanec M; Mardiak J; Mego M; Pinďák D
Klin Onkol; 2019; 32(2):129-132. PubMed ID: 30995853
[TBL] [Abstract][Full Text] [Related]
9. Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumours.
Hartmann JT; Candelaria M; Kuczyk MA; Schmoll HJ; Bokemeyer C
Eur J Cancer; 1997 May; 33(6):843-7. PubMed ID: 9291803
[TBL] [Abstract][Full Text] [Related]
10. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.
Carver BS; Shayegan B; Eggener S; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
J Clin Oncol; 2007 Oct; 25(28):4365-9. PubMed ID: 17906201
[TBL] [Abstract][Full Text] [Related]
11. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors.
Aprikian AG; Herr HW; Bajorin DF; Bosl GJ
Cancer; 1994 Aug; 74(4):1329-34. PubMed ID: 8055456
[TBL] [Abstract][Full Text] [Related]
12. Post-chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study.
Dusaud M; Malavaud B; Bayoud Y; Sebe P; Hoepffner JL; Salomon L; Houlgatte A; Pignot G; Rigaud J; Fléchon A; Pfister C; Rouprêt M; Soulié M; Méjean A; Durand X
J Surg Oncol; 2016 Dec; 114(8):992-996. PubMed ID: 27859263
[TBL] [Abstract][Full Text] [Related]
13. Histopathological assessment of residual retroperitoneal mass removed in patients after chemotherapy for non-seminomatous germ cell tumours of the testis.
Jaszczyński J; Wilk W; Kruczak A; Wohadlo Ł; Faron P; Łuczyńska E; Chłosta P; Stelmach A; Jakubowicz J
Pol J Pathol; 2015 Dec; 66(4):420-5. PubMed ID: 27003776
[TBL] [Abstract][Full Text] [Related]
14. Trans- and extraperitoneal retroperitoneal lymph node dissection (RPLND) in the treatment for nonseminomatous germ cell testicular tumors (NSGCT): a single Chinese center's retrospective analysis.
Tong S; Chen M; Zu X; Li Y; He W; Lei Y; Liu W; Qi L
Int Urol Nephrol; 2014 Feb; 46(2):363-9. PubMed ID: 23996573
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes and histological findings of patients with advanced metastatic germ cell tumors undergoing post-chemotherapy resection of retroperitoneal lymph nodes and residual extraretroperitoneal masses.
Nakamura T; Oishi M; Ueda T; Fujihara A; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
Int J Urol; 2015 Jul; 22(7):663-8. PubMed ID: 25847721
[TBL] [Abstract][Full Text] [Related]
16. Is there still a place for retroperitoneal lymph node dissection in clinical stage 1 nonseminomatous testicular germ-cell tumours? A retrospective clinical study.
Dieckmann KP; Anheuser P; Kulejewski M; Gehrckens R; Feyerabend B
BMC Urol; 2018 Oct; 18(1):95. PubMed ID: 30367648
[TBL] [Abstract][Full Text] [Related]
17. Detailed pathologic analysis on the co-occurrence of non-seminomatous germ cell tumor subtypes in matched orchiectomy and retroperitoneal lymph node dissections.
Spratt DE; Suresh K; Osawa T; Schipper M; Jackson WC; Abugharib A; Lebastchi A; Smith D; Montgomery JS; Palapattu GS; Priya Kunju L; Wu A; Lew M; Tomlins SA; Chinnaiyan AM; Weizer AZ; Hafez KS; Kaffenberger SD; Udager A; Mehra R
Med Oncol; 2018 Jan; 35(3):21. PubMed ID: 29387987
[TBL] [Abstract][Full Text] [Related]
18. Extragonadal germ cell tumour with the "burned out" phenomenon mimicking a retroperitioneal tumour of neurogenic origin.
González R; Montoto Santomé P; Iglesias Porto E; Pérez Moreiras MI; Salem Ali M; Mateo Cambón LA; Bal Nieves F; Arija Val JF
Arch Esp Urol; 2012 Dec; 65(10):900-2. PubMed ID: 23269339
[TBL] [Abstract][Full Text] [Related]
19. Limited post-chemotherapy retroperitoneal resection of residual tumour in non-seminomatous testicular cancer: complications, outcome and quality of life.
Schmidt AH; Høyer M; Jensen BFS; Agerbaek M
Acta Oncol; 2018 Aug; 57(8):1084-1093. PubMed ID: 29537330
[TBL] [Abstract][Full Text] [Related]
20. Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer.
Pearce SM; Golan S; Gorin MA; Luckenbaugh AN; Williams SB; Ward JF; Montgomery JS; Hafez KS; Weizer AZ; Pierorazio PM; Allaf ME; Eggener SE
Eur Urol; 2017 Mar; 71(3):476-482. PubMed ID: 27234998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
